News | April 25, 2026
Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet"
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
Growth was broad-based across segments
With a PhD in Biochemistry and an executive MBA, she brings nearly two decades of experience in the in vitro diagnostics (IVD) sector
Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Analysts expect modest revenue growth but pressure on profitability in the March quarter
Subscribe To Our Newsletter & Stay Updated
